Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2021.745758 Cardiovascular Medicine Original Research Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study Charfeddine Salma 1 2 * Ibn Hadj Amor Hassen 3 Jdidi Jihen 2 4 Torjmen Slim 1 2 Kraiem Salma 3 Hammami Rania 1 2 Bahloul Amine 1 2 Kallel Nesrine 2 5 Moussa Nedia 2 5 Touil Imen 6 Ghrab Aiman 7 Elghoul Jamel 2 8 Meddeb Zineb 9 Thabet Yamina 9 Kammoun Samir 1 2 Bouslama Kamel 9 Milouchi Sami 2 7 Abdessalem Salem 10 Abid Leila 1 2 1Cardiology Department, Hedi Chaker University Hospital Sfax, Sfax, Tunisia 2University of Medicine of Sfax, University of Sfax, Sfax, Tunisia 3Department of Cardiology, Tahar Sfar Hospital Mahdia, Sfax, Tunisia 4Department of Preventive Medicine, Hedi Chaker University Hospital Sfax, Sfax, Tunisia 5Department of Pneumology, Hedi Chaker University Hospital Sfax, Sfax, Tunisia 6Department of Pneumology, Tahar Sfar Hospital Mahdia, Mahdia, Tunisia 7Department of Cardiology, Habib Bourguiba Hospital Medenine, Sfax, Tunisia 8Department of Pneumology, Habib Bourguiba Hospital Medenine, Sfax, Tunisia 9Department of Internal Medicine, Mongi Slim LaMarsa Hospital, Tunis, Tunisia 10Clinic Pasteur Tunis, Tunis, Tunisia

Edited by: Hendrik Tevaearai Stahel, Bern University Hospital, Switzerland

Reviewed by: Ayman Al Haj Zen, Hamad Bin Khalifa University, Qatar; Shunsuke Katsuki, Kyushu University Hospital, Japan; Sarvesh Chelvanambi, Brigham and Women's Hospital and Harvard Medical School, United States

*Correspondence: Salma Charfeddine selma_charfeddine@yahoo.fr

This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine

30 11 2021 2021 8 745758 22 07 2021 28 10 2021 Copyright © 2021 Charfeddine, Ibn Hadj Amor, Jdidi, Torjmen, Kraiem, Hammami, Bahloul, Kallel, Moussa, Touil, Ghrab, Elghoul, Meddeb, Thabet, Kammoun, Bouslama, Milouchi, Abdessalem and Abid. 2021 Charfeddine, Ibn Hadj Amor, Jdidi, Torjmen, Kraiem, Hammami, Bahloul, Kallel, Moussa, Touil, Ghrab, Elghoul, Meddeb, Thabet, Kammoun, Bouslama, Milouchi, Abdessalem and Abid

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

The COVID-19 disease is a multisystem disease due in part to the vascular endothelium injury. Lasting effects and long-term sequelae could persist after the infection and may be due to persistent endothelial dysfunction. Our study focused on the evaluation of endothelial quality index (EQI) by finger thermal monitoring with E4 diagnosis Polymath in a large cohort of long COVID-19 patients to determine whether long-covid 19 symptoms are associated with endothelial dysfunction. This is a cross-sectional multicenter observational study with prospective recruitment of patients. A total of 798 patients were included in this study. A total of 618 patients (77.4%) had long COVID-19 symptoms. The mean EQI was 2.02 ± 0.99 IC95% [1.952.08]. A total of 397 (49.7%) patients had impaired EQI. Fatigue, chest pain, and neuro-cognitive difficulties were significantly associated with endothelium dysfunction with an EQI <2 after adjustment for age, sex, diabetes, hypertension, dyslipidemia, coronary heart disease, and the severity of acute COVID-19 infection. In multivariate analysis, endothelial dysfunction (EQI <2), female gender, and severe clinical status at acute COVID-19 infection with a need for oxygen supplementation were independent risk factors of long COVID-19 syndrome. Long COVID-19 symptoms, specifically non-respiratory symptoms, are due to persistent endothelial dysfunction. These findings allow for better care of patients with long COVID-19 symptoms.

COVID-19 long COVID-19 syndrome endothelial function microcirculation endothelium

香京julia种子在线播放

    1. <form id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></form>
      <address id=HxFbUHhlv><nobr id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></nobr></address>

      Introduction

      The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected in China in December 2019 (1, 2). Up to the time of writing, more than 149 million people worldwide have been infected, and over 3 million people have died from the coronavirus disease 2019 (COVID-19) (3). The COVID-19 disease is a multisystem disease due to in part the vascular endothelium injury it causes (4, 5). Lasting effects and long-term sequelae could persist after the infection, affecting patients' return to work and quality-of-life (6). The most prevalent ongoing symptoms are fatigue, dyspnea, chest pain, joint pain, palpitations, anosmia and dysgeusia, hair loss, cognitive symptoms, and psychosocial distress (611). Some studies suggest that Long-COVID 19 symptoms may be due to persistent endothelial dysfunction (12). In fact, the SARS-CoV-2 infection of endothelial cells is associated with changes in cell morphology and endothelial cells apoptosis that could persist several weeks after the acute infection. The Working Group on Atherosclerosis and Vascular Biology together with the Council of Basic Cardiovascular Science of the European Society of Cardiology provided a Position Statement on the importance of the endothelial function study in convalescent patients for early detection and prevention of long-term cardiovascular complications (4).

      Our study focused on endothelial function evaluation by finger thermal monitoring (FTM) of endothelial quality with an E4-diagnose device (Polymath Company) (13) in a large cohort of long COVID-19 patients.

      The study objectives were defined as the assessment of long COVID 19 symptoms' prevalence, endothelial function in recovered COVID-19 patients, and its link to long COVID-19 symptoms.

      Materials and Methods Study Design

      This was a cross-sectional multicenter observational study with prospective recruitment of patients. The recruiting period extended from January 20 to May 10, 2021. The study protocol was recorded in the Pan African Clinical Trials Registries (PACTR) with trial ID PACTR202102867544936. The study had the local Ethics and Investigation Committee approval, being designated with approval number CPP SUD 0299/2020.

      Participants

      Patients were recruited by local health authorities relying on the COVID-19 registry. After being informed about the study and potential risks, all eligible patients–recovered from confirmed severe acute SARS-CoV2 infection and having given written informed consent–underwent a comprehensive non-invasive assessment of endothelial and cardiac function during their long-COVID19 infection period. Inclusion criteria were as follows: age >18 years, both sexes, written informed consent, and a recent diagnosis of COVID-19 infection in the past 2 weeks−6 months proven by RT-PCR analysis of nasopharyngeal swabs positivity or viral rapid test. Important exclusion criteria included: Diseases carrying a life-expectancy of <1 year according to clinical judgment, pregnancy and breastfeeding, and foreseen inability to attend scheduled visits.

      The long COVID-19 symptoms were defined by persistent symptoms 4 weeks after the start of acute COVID-9 infection (14). These symptoms were assessed simultaneously with the microvascular circulation and endothelial function at the inclusion. An objective evaluation of reported symptoms was performed. Shortness of breath was defined by a New York Heart Association class of dyspnea ≥ 2 (15). Fatigue was evaluated according to the modified fatigue severity scale (16). We used the Mini-Mental State Examination (MMSE) to assess cognitive performances. Cognitive difficulties were defined by an MMSE score <24 (17).

      Test Methods Assessment of Microvascular Circulation and Endothelial Function

      All investigation sites used the E4-diagnose device (Polymath Company. Tunisia) with a fully automated and standardized post occlusion reactive hyperemia procedure (PORH). The E4-diagnose is a non-invasive, high resolution (0.002°C) skin temperature measuring device. It consists of a portable microcontroller (MCU) unit, two accurate finger temperature sensors, and an integrated wrist cuff. All the automated procedures and calculations are fully processed by the embedded MCU firmware. A dedicated PC software views, stores, and exports the data. The tests were carried out in a dimmed and quiet room. The ambient temperature (between 22–24°C) was maintained consistently during the test. The patient was fasting with no smoking nor heavy physical activity, for 4 h prior to the test. At least 20 min were allowed for acclimatization and subjects were kept in a relaxing sitting position. Systolic blood pressure was checked to be <160 mmHg and index fingers temperature above 27°C. The integrated wrist cuff is placed on the dominant forearm and both finger sensors are gently fixed to both index fingers.

      The standard protocol is reported in Supplementary Material, Supplementary Figures 1, 2.

      During TUN-EndCOV study, EQI was selected as the best parameter to reflect the endothelial function relying on the classification below:

      - EQI ≥ 2: Good endothelial function

      - EQI <2: Endothelial dysfunction

      The cut-off of two was in accordance with reported previous data (18) and after statistical validation (Supplementary Material).

      The group endothelial dysfunction was divided into two subgroups with a cut-off of 1.5 for further analysis.

      Echocardiographic Evaluation

      A complete echocardiographic evaluation of the systolic and diastolic left ventricle (LV) function was performed. The LV global longitudinal strain (LVGLS) was determined by the speckle tracking analysis.

      Statistical Analysis

      Statistical analyses were performed using SPSS (Statistical Package for the Social Sciences) version 23.0. The complete database is maintained by the study team. Categorical variables were expressed as frequencies and percentages and continuous variables as mean and SD. Differences in percentages were assessed using the chi-2 test and their means using the Student's t-test. Estimates of risk ratios were presented with 95% Confidence Intervals (CI). All variables that were statistically significant at univariate analysis and those considered of relevant clinical interest with a risk of error of 10% were included in a multivariable model (logistic regression) to identify the independent predictors of endothelial dysfunction and long COVID 19 symptoms and to determine adjusted Odds Ratio (OR). Receiver operating characteristic (ROC) analysis was carried out to determine the cut-off value of continuous variables associated with endothelial dysfunction. A p <0.05 was considered statistically significant.

      Results

      A total of 798 patients were included in this study. Patients were included at an average time of 68.934 ± 3.1 [28–186] days. The mean age was 49.94 ±14.2 years. Women accounted for 60.5 % of patients (483 of 798). Hypertension was the most common chronic health condition, reported in 33%, followed by diabetes in 23.7%. A total of 618 patients (77.4%) had long COVID 19 symptoms. The mean EQI was 2.02 ± 0.99 IC95% [1.95–2.08]. A total of 397 (49.7%) patients had impaired EQI. The demographics, clinical characteristics, long-term medications, endothelial function, and echocardiographic parameters of the study population at inclusion according to the occurrence of long COVID 19 symptoms were reported in Table 1.

      Baseline characteristics of the study population.

      Total population (N = 798) Post COVID 19 symptoms (N = 618) No post COVID 19 symptoms (N = 180) p-value
      Clinical characteristics
      Age (years) 49.94 ± 14.2 50.03 ± 14.2 49.65 ± 14.3 0.75
      BMI (kg/m2) 28.34 ± 4.7 28.35 ± 4.6 28.32 ± 4.8 0.94
      Females (n, %) 483 (60.5) 389 (62.9) 94 (52.2) 0.01
      Diabetes (n, %) 189 (23.7) 153 (24.8) 36 (20.0) 0.18
      Hypertension (n, %) 269 (33.7) 207 (33.5) 62 (34.4) 0.81
      Dyslipidemia (n, %) 84 (10.5) 69 (11.2) 15 (8.3) 0.27
      Smoking (n, %) 57 (7.1) 41 (6.6) 16 (8.9) 0.30
      CV risk factors
      0 397 (49.7) 305 (49.4) 92 (51.1) 0.68
      1 195 (24.4) 157 (25.4) 38 (21.1)
      2 130 (16.3) 89 (15.9) 32 (17.8)
      ≥3 76 (9.5) 58 (9.4) 18 (10.0)
      Heart failure (n, %) 4 (0.5) 3 (0.5) 1 (0.6) 0.64
      Coronary heart disease (n, %) 34 (4.3) 25 (4.0) 9 (5.0) 0.57
      Pulmonary disease (n, %) 48 (6.0) 42 (6.8) 6 (3.3) 0.08
      Chronic medications before trial
      Aspirin (n, %) 70 (8.8) 55 (8.9) 15 (8.3) 0.81
      ACE inhibitors (n, %) 103 (12.9) 84 (13.6) 19 (10.6) 0.28
      ARBs (n, %) 58 (7.3) 53 (8.6) 5 (2.8) 0.008
      Bblockers (n, %) 84 (10.5) 56 (9.1) 29 (16.1) 0.007
      Statins (n, %) 107 (13.4) 87 (14.1) 20 (11.1) 0.30
      Calcium channel blockers (n, %) 37 (4.6) 29 (4.7) 8 (4.4) 0.88
      Nitrates (n, %) 6 (0.8) 3 (0.5) 3 (1.7) 0.10
      Severity of COVID 19 infection
      Moderate or severe symptoms (need of oxygen) (n, %) 185 (23.2) 159 (25.7) 26 (14.4) 0.002
      Extend of lesions at thoracic CT scan
      ≥50 % (n, %) 36 (4.5) 32 (5.2) 4 (2.2) 0.09
      Endothelial function parameters
      EQI 2.02 ± 0.9 1.99 ± 0.9 2.09 ± 1.0 0.24
      Flow_ratio 5.02 ± 3.2 5.02 ± 3.2 5.00 ± 3.3 0.93
      Peak_time 51.86 ± 29.9 50.97 ± 28.5 54.95 ± 34.4 0.12
      Half_time_decay 36.10 ± 17.5 35.74 ± 16.6 37.13 ± 19.9 0.42
      Endothelial dysfunction (EQI <2) 397 (49.7) 319 (51.6) 78 (43.3) 0.05
      Echocardiographic parameters
      LVEF (%) 61.00 ± 5.3 60.94 ± 5.3 61.30 ± 5.1 0.65
      LVGLS (%) −16.96 ± 2.7 −16.84 ± 2.6 −17.63 ± 2.8 0.07
      E-wave velocity (cm/sec) 79.33 ± 19.0 79.21 ± 19.2 79.91 ± 18.2 0.81
      A-wave velocity (cm/sec) 74.15 ± 18.2 73.74 ± 18.5 76.11 ± 16.7 0.40
      E' velocity (cm/sec) 13.81 ± 3.9 13.64 ± 3.7 14.57 ± 5.0 0.13
      E/E' 6.09 ± 2.1 6.08 ± 2.0 6.14 ± 2.5 0.87
      sPAP (mmHg) 21.64 ± 7.2 21.77 ± 7.4 21.06 ± 6.4 0.53
      Elevated LV filling pressure (n, %) 2 (0.3) 1 (0.2) 1 (0.6) 0.4

      ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers; BMI, body mass index; CV, cardiovascular; EQI, endothelium quality index; LVEF, left ventricular ejection fraction; LVGLS, left ventricular global longitudinal strain; E, transmitral early diastolic peak velocity; A, late diastolic peak velocity; E', early relaxation velocity on tissue Doppler; sPAP, systolic pulmonary artery pressure. Bold values mean statistically significant difference.

      Among long COVID-19 symptoms, fatigue was the most common symptom reported in 42.2%, followed by shortness of breath in 41.5%, headaches in 22.1%, and chest pain in 20.3%.

      Long COVID-19 symptoms were associated with endothelium dysfunction with an EQI <2 (Table 2). Fatigue, chest pain, and neuro-cognitive difficulties were significantly associated with an EQI <2 after adjustment for age, sex, diabetes, hypertension, dyslipidemia, coronary heart disease, and the severity of acute COVID-19 infection (need for oxygen) (Table 2). Long COVID-19 symptoms were not associated with the severity of the endothelial dysfunction in the subgroups analysis.

      Adjusted associations of different long COVID 19 symptoms to endothelial dysfunction.

      Total population (n = 798) EQI ≥ 2 (n = 401) EQI <2 (n = 397) p-value OR95% Adjusted* OR95%
      ≥ 1 symptom (n, %) 618 (77.4) 299 (74.5) 319 (80.3) 0.05 1.39 [0.99–1.39] 1.45 [1.02–2.07], p = 0.03
      Chest pain, dyspnea or fatigue (n, %) 546 (68.4) 256 (63.8) 296 (73) 0.005 1.53 [1.13– 2.07] 1.50 [1.09-2.07], p = 0.01
      Fatigue (n, %) 337 (42.2) 155 (38.7) 182 (45.8) 0.04 1.34 [1.01–1.78] 1.36 [1.01, 1.83], p = 0.038
      Chest pain (n, %) 162 (20.3) 62 (15.5) 100 (25.2) 0.001 1.84 [1.29–2.62] 1.94 [1.34–2.80], p <0.001
      Palpitations (n, %) 139 (17.4) 78 (19.5) 61 (15.4) 0.12 0.75 [0.52–1.08] 0.84 [0.57–1.24], p = 0.40
      Shortness of breath (n, %) 331 (41.5) 159 (39.7) 172 (43.3) 0.29 1.16 [0.87–1.54] 1.12 [0.83- 1.52], p = 0.44
      Cough (n, %) 136 (17) 63 (15.7) 73 (18.4) 0.31 1.20 [0.83–1.75] 1.15 [0.78–1.69], p = 0.47
      Headaches (n, %) 176 (22.1) 86 (21.4) 90 (22.7) 0.67 1.07 [0.76–1.50] 1.26 [0.88–1.79], p = 0.19
      Anosmia (n, %) 28 (3.5) 15 (3.7) 13 (3.3) 0.72 0.87 [0.40–1.85] 1.06 [0.47 – 2.35], p = 0.88
      Gastro-intestinal syndrome (n, %) 47 (5.9) 18 (4.5) 29 (7.3) 0.09 1.67 [0.91–3.07] 1.62 [0.86–3.05], p = 0.13
      Neuro-cognitive difficulties (n, %) 97 (12.2) 44 (11.0) 53 (13.4) 0.30 1.25 [0.81–1.91] 1.62 [1.03–2.55], p = 0.036
      Sleep disorders 76 (9.5) 34 (8.5) 42 (10.6) 0.31 1.27 [0.79–2.05] 1.45 [0.88–2.40], p = 0.13

      Adjusted to age, sex, diabetes, hypertension, dyslipidemia, coronary heart disease, and severe clinical status of COVID 19 infection with the need for oxygen.

      EQI, endothelium quality index; OR, odds ratio.

      In multivariate analysis, endothelial dysfunction (EQI <2), female gender, and severe clinical status at acute COVID-19 infection with a need for oxygen supplementation were independent risk factors of long COVID-19 syndrome (Table 3).

      Associated factors to long COVID-19 syndrome in multivariate analysis.

      Variable Odds Ratio, 95 CI% P
      EQI <2 1.522 (1.072–2.160) 0.019
      Female gender 1.913 (1.340–2.731) <10−3
      Severe clinical status of COVID 19 infection with need to oxygen 2.394 (1.495–3.833) <10−3
      B-blockers 0.489 (0.296–0.806) 0.005

      EQI, endothelium quality index.

      Endothelial dysfunction was significantly associated with the older age, body mass index (BMI), male gender, cardiovascular risk factors, the severity of symptoms during the acute phase of COVID-19 infection, the extension of pulmonary lesions during the COVID-19 infection, and reduced LV GLS (Table 4).

      Baseline characteristics in the study population according to endothelium quality index.

      Total population (n = 798) EQI ≥ 2 (n = 401) Impaired EQI <2 (n = 397) p-value
      Clinical characteristics
      Age (years) 49.94 ± 14.2 47.21 ± 14.5 52.71 ± 13.4 <10−3
      BMI (kg/m2) 28.34 ± 4.7 27.55 ± 4.6 29.14 ± 4.6 <10−3
      Females (n, %) 483 (60.5) 279 (69.6) 204 (51.4) <10−3
      Diabetes (n, %) 189 (23.7) 75 (18.7) 114 (28.7) 0.001
      Hypertension (n, %) 269 (33.7) 112 (27.9) 157 (39.5) 0.001
      Dyslipidemia (n, %) 84 (10.5) 26 (6.5) 58 (14.6) <10−3
      Smoking (n, %) 57 (7.1) 28 (7.0) 29 (7.3) 0.86
      CV risk factors
      0 365 (45.7) 213 (53.1) 152 (38.3) <10−3
      1 223 (27.9) 108 (26.9) 115 (29.0)
      2 125 (15.7) 48 (12.0) 77 (19.4)
      ≥3 85 (10.7) 32 (8.0) 53 (13.4)
      Heart failure (n, %) 4 (0.5) 1 (0.2) 3 (0.8) 0.31
      Coronary heart disease (n, %) 34 (4.3) 10 (2.5) 24 (6.0) 0.01
      Pulmonary disease (n, %) 48 (6.0) 26 (6.5) 22 (5.5) 0.57
      Chronic medications before trial
      Aspirin (n, %) 70 (8.8) 19 (4.7) 51 (12.8) <10−3
      ACE inhibitors (n, %) 103 (12.9) 41 (10.2) 62 (15.6) 0.02
      ARBs (n, %) 58 (7.3) 19 (4.7) 39 (9.8) 0.006
      Bblockers (n, %) 84 (10.5) 34 (8.5) 50 (12.6) 0.05
      Statins (n, %) 107 (13.4) 31 (7.7) 76 (19.1) <10−3
      Severity of COVID 19 infection
      Moderate or severe symptoms (need of oxygen) (n, %) 185 (23.2) 72 (18.0) 113 (28.5) <10−3
      Extend of lesions at thoracic CT scan
      ≥50 % (n, %) 36 (4.5) 11 (2.7) 25 (6.3) 0.01
      Echocardiography
      LVEF (%) 61.00 ± 5.3 61.93 ± 5.3 60.16 ± 5.1 0.004
      LVGLS (%) −16.96 ± 2.7 −18.19 ± 2.3 −15.89 ± 2.5 <10−3
      E-wave velocity (cm/sec) 79.33 ± 19.0 83.49 ± 16.8 75.50 ± 20.1 <10−3
      A-wave velocity (cm/sec) 74.15 ± 18.2 73.69 ± 17.5 74.58 ± 18.9 0.68
      E' velocity (cm/sec) 13.81 ± 3.9 14.79 ± 4.0 12.9 ± 3.6 <10−3
      E/E' 6.09 ± 2.1 5.95 ± 1.7 6.22 ± 2.4 0.28
      sPAP (mmHg) 21.64 ± 7.2 20.97 ± 7.7 22.26 ± 6.7 0.13
      Elevated LV filling pressure 2 (0.3) 0 2 (0.5) 0.24

      ACEI, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor antagonists (ARBs); BMI, body mass index; CV, cardiovascular; EQI, endothelium quality index; LV, left ventricle, LVEF, left ventricular ejection fraction; LVGLS, left ventricular global longitudinal strain; E, transmitral early diastolic peak velocity; A, late diastolic peak velocity; E', early relaxation velocity on tissue Doppler; sPAP, systolic pulmonary artery pressure.

      According to ROC analysis, 45 years old, 25kg/m2, and−16% were the optimal cut-off values respectively for age, BMI, and LVGLS associated with endothelial dysfunction (Supplementary Figure 3). In multivariate analysis, age ≥ 45 years old, reduced LVGLS < -16%, and dyslipidemia were significantly associated with endothelial dysfunction (Table 5).

      Associated factors to endothelial dysfunction in multivariate analysis.

      Variable Odds Ratio, 95 CI% p
      Age > 45 years old 2.046 (1.151–3.635) 0.01
      Reduced LVGLS 4.540 (2.451–8.410) <10−3
      Dyslipidemia 2.834 (1.042–7.713) 0.04

      BMI, body mass index; LVGLS, left ventricle global longitudinal strain.

      Discussion

      COVID-19 is a multisystem disease due to in part endothelium damage (4, 5). SARS-CoV-2 infects the host using the angiotensin-converting enzyme 2 (ACE2) receptors, which are expressed in several organs, including the lung, heart, kidney, intestine, and also expressed by endothelial cells, causing a distinguishable and distinct systemic endotheliitis (5, 19).

      Lasting sequalae, symptoms, signs, or abnormal clinical parameters persisting 4 weeks or more after COVID-19 infection onset were commonly defined as “long COVID-19” (14, 2022).

      While it is well established that endothelial dysfunction is associated with poor prognosis in acute phase COVID19, its link with long COVID 19 symptoms is still questionable.

      This study (1) reported long COVID-19 data in a large cohort of patients and (2) focused on endothelial dysfunction as a possible mechanism of underlying persistent long COVID-19 symptoms.

      Our findings support that long COVID 19 syndrome is frequent. Recent reviews and metanalysis evaluated and summarized the best available evidence on the frequency of long COVID-19 (6, 11) (Table 6). Persistent long COVID-19 symptoms were reported until 6 months after the acute phase (23).

      Prevalence of long COVID-19 symptoms in the literature.

      TUN-End-COV study Systematic review and metanalysis of Lopez Leon et al. (6) Systematic review of Cabrera Martimbianco et al. (11)
      At least one symptom (%) 77.4 80 4.7–80
      Fatigue (%) 42.2 58 6.6–64.0
      Chest pain (%) 20.3 16 0.4–89
      Palpitations (%) 17.4 22 13
      Shortness of breath (%) 41.5 24 5.5–61
      Cough (%) 17 19 1.8–59.0
      Headaches (%) 22.1 44 2.0–39.0
      Anosmia (%) 3.5 - 0–26.2
      Gastro-intestinal syndrome (%) 5.9 12 1.3–33.3
      Neuro-cognitive difficulties (%) 12.2 43 18–57.1

      Different risk factors such as old age, a high number of comorbidities, severe clinical status, hospital admission, and oxygen supplementation at the acute COVID-19 phase were reported as potentially associated with long COVID-19 symptoms (8, 10, 2426). TUN-EndCOV study showed that persistent symptoms especially chest pain, fatigue, and neurocognitive symptoms (non-respiratory symptoms) during the long COVID-19 period were mainly associated with endothelial dysfunction, even after adjustment for age, sex, diabetes, hypertension, dyslipidemia, coronary heart disease, and severe clinical status of COVID-19 infection with the need for oxygen. In multivariate analysis, endothelial dysfunction was an independent risk factor of long COVID-19 syndrome. A recent case reported a non-amelioration of vascular reactivity 3 weeks after acute COVID-19 infection (27). A small-sized pilot study in patients with critical COVID-19 suggested that microvascular function assessed by Laser Speckle Contrast Imaging may not be fully recovered 3 months after disease onset (28).

      The beta-blockers treatment was associated with reduced long COVID-19 symptoms. In fact, some papers suggested that beta-adrenergic blockers may be associated with beneficial effects during the acute COVID-19 infection by decreasing the SARS-CoV-2 virus entry, inhibiting NLRP3 inflammasome, reducing IL-6 and so that decreasing the consequent cardio-vascular and pulmonary acute COVID-19 complications (29). These mechanisms may also explain the long-term cardio-pulmonary COVID-19 symptoms. Furthermore, this benefit could be explained in part by beta-blockers pleiotropic effects on the endothelium (reduction of the myocardial oxygen consumption, and anti-oxidant properties) and their effect on rate control (30).

      In this large cohort of long COVID-19 population, endothelial function was evaluated by an FTM of the endothelium quality with E4-diagnose device (Polymath Company. Tunisia) (13). It has been shown that the FTM can be used as a reproducible and operator-independent test for the non-invasive measurement of endothelial function in a controlled environment (31). In the largest report to date on any fingertip-based measurement of vascular reactivity and endothelial function, the vascular reactivity index (VRI) values were inversely correlated with age and male gender (18). Even so, the distribution of VRI values in the elderly population and between genders clearly showed a sizable number of good and intermediate scores (18). These findings support the clinical utility of FTM as a test that can differentiate good vascular function from poor vascular function, regardless of the characteristics of the patient (18). In the present study, older age and subclinical LV systolic dysfunction measured by LVGLS were an independently associated factor to impaired EQI. In previous studies, subclinical myocardial deformation with reduced LVGLS was reported at one-month follow-up in one out of every three patients recovered from COVID 19 infection, even in those without myocardial injury (32). The alteration of LVGLS associated with endothelial dysfunction following COVID-19 infection may be due to different factors: (1) the cardiomyocyte inflammation due to viral infiltration (33) and immune mechanisms (34, 35) (2) the hypoxia due to respiratory failure (34, 36), and (3) the myocardial injury due to microvascular dysfunction (19, 37, 38). This finding could explain the persistent chest pain during the long COVID-19.

      This is the largest and the first study up to date that focused on the non-invasive evaluation of endothelial function by FTM during the long COVID-19. An important finding is the probable association of “non-respiratory” long COVID-19 symptoms especially chest pain, fatigue, and neuro-cognitive difficulties to endothelial dysfunction, highlighting the importance of an early evaluation of the endothelium quality for appropriate management. Understanding the pathophysiology and underlying mechanisms of persistent symptoms in long COVID-19 patients is required to guide investigations, management and improve patient prognosis.

      Further studies are required to characterize long COVID-19 vascular sequelae in order to develop a planned monitoring program and adequate treatment.

      Limitations and Perspectives

      One limitation of the study could be that reported symptoms were collected by a physician and not through self-reports, so probably only significant symptoms were reported. Furthermore, a global evaluation of the quality of life of the patients was not reported. Another study limitation could be the absence of data on whether patients with endothelial dysfunction had any subclinical preexistent endothelial dysfunction before COVID-19 infection especially in the elderly. In fact, age was one of the most important factors associated with endothelial dysfunction in our study. Longitudinal follow-up of individuals with long COVID-19 syndrome and endothelial dysfunction is warranted to better understand the pathophysiology underlying the long-term persistence and to guide therapeutic intervention. Randomized studies are requested to study the effect of treatment with action on the endothelium function such as Beta-blockers, ACE inhibitors, ARBs, and statins on the long COVID-19 symptoms. Finally, lack of control data regarding endothelial function evaluation in patients with similar demographic characteristics without COVID-19 infection could be one of the study limitations.

      Conclusion

      There is increasing evidence regarding the link between endothelial dysfunction and persistent long COVID-19 symptoms. Risk stratification of long COVID-19 patients may be important to their management. The evaluation of endothelium quality by FTM to non-invasively detect endothelial dysfunction needs to be studied further to improve the management of long COVID-19 patients.

      Data Availability Statement

      The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

      Ethics Statement

      The studies involving human participants were reviewed and approved by CPP SUD 0299/2020. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

      Author Contributions

      LA, SA, SC, and HI: conception and design of the study and literature review. JJ, SC, SA, and LA: analysis and interpretation of the data. SC: drafting of the manuscript. LA and SA: revising and editing the manuscript. All authors: data collection.

      Conflict of Interest

      The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

      Publisher's Note

      All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

      Supplementary Material

      The Supplementary Material for this article can be found online at: /articles/10.3389/fcvm.2021.745758/full#supplementary-material

      References Huang C Wang Y Li X Ren L Zhao J Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl. (2020) 395:497506. 10.1016/S0140-6736(20)30183-532502551 Zhu N Zhang D Wang W Li X Yang B Song J . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:72733. 10.1056/NEJMoa200101731978945 Johns Hopkins Coronavirus Resource Center. (2021). Available online at: https://coronavirus.jhu.edu/ (accessed September 26, 2021). Evans PC Rainger GE Mason JC Guzik TJ Osto E Stamataki Z . Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for atherosclerosis and vascular biology, and the esc council of basic cardiovascular science. Cardiovasc Res. (2020) 116:217784. 10.1093/cvr/cvaa23032750108 Osuchowski MF Winkler MS Skirecki T Cajander S Shankar-Hari M Lachmann G . The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. (2021) 9:P622642. 10.1016/S2213-2600(21)00218-633965003 Lopez-Leon S Wegman-Ostrosky T Perelman C Sepulveda R Rebolledo P Cuapio A . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. (2021) 11:16144. 10.21203/rs.3.rs-266574/v134373540 Yelin D Margalit I Yahav D Runold M Bruchfeld J. Long COVID-19-it's not over until? Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. (2021) 27:5068. 10.1016/j.cmi.2020.12.00133316400 Xiong Q Xu M Li J Liu Y Zhang J Xu Y . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. (2021) 27:8995. 10.1016/j.cmi.2020.09.02332979574 Carfì A Bernabei R Landi F Gemelli. Against COVID-19 post-acute care study group. persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:6035. 10.1001/jama.2020.1260332644129 Carvalho-Schneider C Laurent E Lemaignen A Beaufils E Bourbao-Tournois C Laribi S . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. (2021) 27:25863. 10.1016/j.cmi.2020.09.05233031948 Cabrera Martimbianco AL Pacheco RL Bagattini ÂM Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID: a systematic review. Int J Clin Pract. (2021) 75:e14357. 10.1111/ijcp.1435733977626 Østergaard L SARS. CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. (2021) 9:e14726. 10.14814/phy2.1472633523608 polymath-Diagnose User Manual.pdf. Shah W Hillman T Playford ED Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. (2021) 372:n136. 10.1136/bmj.n13633483331 Yap J Lim FY Gao F Teo LL Lam CSP Yeo KK. Correlation of the New York heart association classification and the 6-minute walk distance: a systematic review. Clin Cardiol. (2015) 38:6218. 10.1002/clc.2246826442458 Kos D Kerckhofs E Carrea I Verza R Ramos M Jansa J. Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler Houndmills Basingstoke Engl. (2005) 11:7680. 10.1191/1352458505ms1117oa15732270 Pangman VC Sloan J Guse L. An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice. Appl Nurs Res ANR. (2000) 13:20913. 10.1053/apnr.2000.923111078787 Naghavi M Yen AA Lin AWH Tanaka H Kleis S. New indices of endothelial function measured by digital thermal monitoring of vascular reactivity: data from 6084 patients registry. Int J Vasc Med. (2016) 2016:1348028. 10.1155/2016/134802827830091 Varga Z Flammer AJ Steiger P Haberecker M Andermatt R Zinkernagel AS . Endothelial cell infection and endotheliitis in COVID-19. The Lancet. (2020) 395:14178. 10.1016/S0140-6736(20)30937-532325026 Tenforde MW Kim SS Lindsell CJ Billig Rose E Shapiro NI Files DC . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:9938. 10.15585/mmwr.mm6930e132730238 Silva Andrade B Siqueira S de Assis Soares WR de Souza Rangel F Santos NO Dos Santos Freitas A . Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. (2021) 13:700. 10.3390/v1304070033919537 Townsend L Dowds J O'Brien K Sheill G Dyer AH O'Kelly B . Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. (2021) 18:9971003. 10.1513/AnnalsATS.202009-1175OC33413026 Ghosn J Piroth L Epaulard O Le Turnier P Mentré F Bachelet D . Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. (2021) 27:1041.e1–e4. 10.1016/j.cmi.2021.03.01234125067 Bellan M Soddu D Balbo PE Baricich A Zeppegno P Avanzi GC . Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. (2021) 4:e2036142. 10.1001/jamanetworkopen.2020.3614233502487 Huang C Huang L Wang Y Li X Ren L Gu X . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet Lond Engl. (2021) 397:22032. 10.1016/S0140-6736(20)32656-833428867 Jacobs LG Gourna Paleoudis E Lesky-Di Bari D Nyirenda T Friedman T Gupta A . Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. (2020) 15:e0243882. 10.1371/journal.pone.024388233306721 Jud P Kessler HH and Brodmann M. Case report: changes of vascular reactivity and arterial stiffness in a patient with covid-19 infection. Front Cardiovasc Med. (2021) 8:671669. 10.3389/fcvm.2021.67166934055940 Tehrani S Gille-Johnson P. Microvascular dysfunction in patients with critical COVID-19, a pilot study. Shock. (2021) 56:9648. 10.1097/SHK.000000000000180333958544 Vasanthakumar N. Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients. BioEssays News Rev Mol Cell Dev Biol. (2020) 42:e2000094. 10.1002/bies.20200009432815593 Kunadian V Chieffo A Camici PG Berry C Escaned J Maas AHEM . An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group. Eur Heart J. (2020) 41:350420. 10.1093/eurheartj/ehaa50332626906 Ahmadi N McQuilkin GL Akhtar MW Hajsadeghi F Kleis SJ Hecht H . Reproducibility and variability of digital thermal monitoring of vascular reactivity. Clin Physiol Funct Imaging. (2011) 31:4228. 10.1111/j.1475-097X.2011.01037.x21981452 Özer S Candan L Özyildiz AG Turan OE. Evaluation of left ventricular global functions with speckle tracking echocardiography in patients recovered from COVID-19. Int J Cardiovasc Imaging. (2021) 37:2227-33. 10.1007/s10554-021-02211-533725265 Akhmerov A Marbán E. COVID-19 and the Heart. Circ Res. (2020) 126:144355. 10.1161/CIRCRESAHA.120.31705532252591 Chen C Zhou Y Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. (2020) 45:2302. 10.1007/s00059-020-04909-z32140732 Madjid M Safavi-Naeini P Solomon SD Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. (2020) 5:83140. 10.1001/jamacardio.2020.128632219363 Inciardi RM Lupi L Zaccone G Italia L Raffo M Tomasoni D . Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:81924. 10.1001/jamacardio.2020.109632219357 Tajbakhsh A Gheibi Hayat SM Taghizadeh H Akbari A Inabadi M Savardashtaki A . COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. (2021) 19:34557. 10.1080/14787210.2020.182273732921216 Fox SE Li G Akmatbekov A Harbert JL Lameira FS Brown JQ . Unexpected features of cardiac pathology in COVID-19 infection. Circulation. (2020) 142:11235. 10.1161/CIRCULATIONAHA.120.04946532689809
      ‘Oh, my dear Thomas, you haven’t heard the terrible news then?’ she said. ‘I thought you would be sure to have seen it placarded somewhere. Alice went straight to her room, and I haven’t seen her since, though I repeatedly knocked at the door, which she has locked on the inside, and I’m sure it’s most unnatural of her not to let her own mother comfort her. It all happened in a moment: I have always said those great motor-cars shouldn’t be allowed to career about the streets, especially when they are all paved with cobbles as they are at Easton Haven, which are{331} so slippery when it’s wet. He slipped, and it went over him in a moment.’ My thanks were few and awkward, for there still hung to the missive a basting thread, and it was as warm as a nestling bird. I bent low--everybody was emotional in those days--kissed the fragrant thing, thrust it into my bosom, and blushed worse than Camille. "What, the Corner House victim? Is that really a fact?" "My dear child, I don't look upon it in that light at all. The child gave our picturesque friend a certain distinction--'My husband is dead, and this is my only child,' and all that sort of thing. It pays in society." leave them on the steps of a foundling asylum in order to insure [See larger version] Interoffice guff says you're planning definite moves on your own, J. O., and against some opposition. Is the Colonel so poor or so grasping—or what? Albert could not speak, for he felt as if his brains and teeth were rattling about inside his head. The rest of[Pg 188] the family hunched together by the door, the boys gaping idiotically, the girls in tears. "Now you're married." The host was called in, and unlocked a drawer in which they were deposited. The galleyman, with visible reluctance, arrayed himself in the garments, and he was observed to shudder more than once during the investiture of the dead man's apparel. HoME香京julia种子在线播放 ENTER NUMBET 0016www.lshbrl.org.cn
      www.hxchain.com.cn
      kmhtad.com.cn
      jollymama.com.cn
      www.hckylu.com.cn
      www.r06.com.cn
      supplyx.com.cn
      www.qzship.com.cn
      www.mrryen.org.cn
      www.nkchain.com.cn
      处女被大鸡巴操 强奸乱伦小说图片 俄罗斯美女爱爱图 调教强奸学生 亚洲女的穴 夜来香图片大全 美女性强奸电影 手机版色中阁 男性人体艺术素描图 16p成人 欧美性爱360 电影区 亚洲电影 欧美电影 经典三级 偷拍自拍 动漫电影 乱伦电影 变态另类 全部电 类似狠狠鲁的网站 黑吊操白逼图片 韩国黄片种子下载 操逼逼逼逼逼 人妻 小说 p 偷拍10幼女自慰 极品淫水很多 黄色做i爱 日本女人人体电影快播看 大福国小 我爱肏屄美女 mmcrwcom 欧美多人性交图片 肥臀乱伦老头舔阴帝 d09a4343000019c5 西欧人体艺术b xxoo激情短片 未成年人的 插泰国人夭图片 第770弾み1 24p 日本美女性 交动态 eee色播 yantasythunder 操无毛少女屄 亚洲图片你懂的女人 鸡巴插姨娘 特级黄 色大片播 左耳影音先锋 冢本友希全集 日本人体艺术绿色 我爱被舔逼 内射 幼 美阴图 喷水妹子高潮迭起 和后妈 操逼 美女吞鸡巴 鸭个自慰 中国女裸名单 操逼肥臀出水换妻 色站裸体义术 中国行上的漏毛美女叫什么 亚洲妹性交图 欧美美女人裸体人艺照 成人色妹妹直播 WWW_JXCT_COM r日本女人性淫乱 大胆人艺体艺图片 女同接吻av 碰碰哥免费自拍打炮 艳舞写真duppid1 88电影街拍视频 日本自拍做爱qvod 实拍美女性爱组图 少女高清av 浙江真实乱伦迅雷 台湾luanlunxiaoshuo 洛克王国宠物排行榜 皇瑟电影yy频道大全 红孩儿连连看 阴毛摄影 大胆美女写真人体艺术摄影 和风骚三个媳妇在家做爱 性爱办公室高清 18p2p木耳 大波撸影音 大鸡巴插嫩穴小说 一剧不超两个黑人 阿姨诱惑我快播 幼香阁千叶县小学生 少女妇女被狗强奸 曰人体妹妹 十二岁性感幼女 超级乱伦qvod 97爱蜜桃ccc336 日本淫妇阴液 av海量资源999 凤凰影视成仁 辰溪四中艳照门照片 先锋模特裸体展示影片 成人片免费看 自拍百度云 肥白老妇女 女爱人体图片 妈妈一女穴 星野美夏 日本少女dachidu 妹子私处人体图片 yinmindahuitang 舔无毛逼影片快播 田莹疑的裸体照片 三级电影影音先锋02222 妻子被外国老头操 观月雏乃泥鳅 韩国成人偷拍自拍图片 强奸5一9岁幼女小说 汤姆影院av图片 妹妹人艺体图 美女大驱 和女友做爱图片自拍p 绫川まどか在线先锋 那么嫩的逼很少见了 小女孩做爱 处女好逼连连看图图 性感美女在家做爱 近距离抽插骚逼逼 黑屌肏金毛屄 日韩av美少女 看喝尿尿小姐日逼色色色网图片 欧美肛交新视频 美女吃逼逼 av30线上免费 伊人在线三级经典 新视觉影院t6090影院 最新淫色电影网址 天龙影院远古手机版 搞老太影院 插进美女的大屁股里 私人影院加盟费用 www258dd 求一部电影里面有一个二猛哥 深肛交 日本萌妹子人体艺术写真图片 插入屄眼 美女的木奶 中文字幕黄色网址影视先锋 九号女神裸 和骚人妻偷情 和潘晓婷做爱 国模大尺度蜜桃 欧美大逼50p 西西人体成人 李宗瑞继母做爱原图物处理 nianhuawang 男鸡巴的视屏 � 97免费色伦电影 好色网成人 大姨子先锋 淫荡巨乳美女教师妈妈 性nuexiaoshuo WWW36YYYCOM 长春继续给力进屋就操小女儿套干破内射对白淫荡 农夫激情社区 日韩无码bt 欧美美女手掰嫩穴图片 日本援交偷拍自拍 入侵者日本在线播放 亚洲白虎偷拍自拍 常州高见泽日屄 寂寞少妇自卫视频 人体露逼图片 多毛外国老太 变态乱轮手机在线 淫荡妈妈和儿子操逼 伦理片大奶少女 看片神器最新登入地址sqvheqi345com账号群 麻美学姐无头 圣诞老人射小妞和强奸小妞动话片 亚洲AV女老师 先锋影音欧美成人资源 33344iucoom zV天堂电影网 宾馆美女打炮视频 色五月丁香五月magnet 嫂子淫乱小说 张歆艺的老公 吃奶男人视频在线播放 欧美色图男女乱伦 avtt2014ccvom 性插色欲香影院 青青草撸死你青青草 99热久久第一时间 激情套图卡通动漫 幼女裸聊做爱口交 日本女人被强奸乱伦 草榴社区快播 2kkk正在播放兽骑 啊不要人家小穴都湿了 www猎奇影视 A片www245vvcomwwwchnrwhmhzcn 搜索宜春院av wwwsee78co 逼奶鸡巴插 好吊日AV在线视频19gancom 熟女伦乱图片小说 日本免费av无码片在线开苞 鲁大妈撸到爆 裸聊官网 德国熟女xxx 新不夜城论坛首页手机 女虐男网址 男女做爱视频华为网盘 激情午夜天亚洲色图 内裤哥mangent 吉沢明歩制服丝袜WWWHHH710COM 屌逼在线试看 人体艺体阿娇艳照 推荐一个可以免费看片的网站如果被QQ拦截请复制链接在其它浏览器打开xxxyyy5comintr2a2cb551573a2b2e 欧美360精品粉红鲍鱼 教师调教第一页 聚美屋精品图 中韩淫乱群交 俄罗斯撸撸片 把鸡巴插进小姨子的阴道 干干AV成人网 aolasoohpnbcn www84ytom 高清大量潮喷www27dyycom 宝贝开心成人 freefronvideos人母 嫩穴成人网gggg29com 逼着舅妈给我口交肛交彩漫画 欧美色色aV88wwwgangguanscom 老太太操逼自拍视频 777亚洲手机在线播放 有没有夫妻3p小说 色列漫画淫女 午间色站导航 欧美成人处女色大图 童颜巨乳亚洲综合 桃色性欲草 色眯眯射逼 无码中文字幕塞外青楼这是一个 狂日美女老师人妻 爱碰网官网 亚洲图片雅蠛蝶 快播35怎么搜片 2000XXXX电影 新谷露性家庭影院 深深候dvd播放 幼齿用英语怎么说 不雅伦理无需播放器 国外淫荡图片 国外网站幼幼嫩网址 成年人就去色色视频快播 我鲁日日鲁老老老我爱 caoshaonvbi 人体艺术avav 性感性色导航 韩国黄色哥来嫖网站 成人网站美逼 淫荡熟妇自拍 欧美色惰图片 北京空姐透明照 狼堡免费av视频 www776eom 亚洲无码av欧美天堂网男人天堂 欧美激情爆操 a片kk266co 色尼姑成人极速在线视频 国语家庭系列 蒋雯雯 越南伦理 色CC伦理影院手机版 99jbbcom 大鸡巴舅妈 国产偷拍自拍淫荡对话视频 少妇春梦射精 开心激动网 自拍偷牌成人 色桃隐 撸狗网性交视频 淫荡的三位老师 伦理电影wwwqiuxia6commqiuxia6com 怡春院分站 丝袜超短裙露脸迅雷下载 色制服电影院 97超碰好吊色男人 yy6080理论在线宅男日韩福利大全 大嫂丝袜 500人群交手机在线 5sav 偷拍熟女吧 口述我和妹妹的欲望 50p电脑版 wwwavtttcon 3p3com 伦理无码片在线看 欧美成人电影图片岛国性爱伦理电影 先锋影音AV成人欧美 我爱好色 淫电影网 WWW19MMCOM 玛丽罗斯3d同人动画h在线看 动漫女孩裸体 超级丝袜美腿乱伦 1919gogo欣赏 大色逼淫色 www就是撸 激情文学网好骚 A级黄片免费 xedd5com 国内的b是黑的 快播美国成年人片黄 av高跟丝袜视频 上原保奈美巨乳女教师在线观看 校园春色都市激情fefegancom 偷窥自拍XXOO 搜索看马操美女 人本女优视频 日日吧淫淫 人妻巨乳影院 美国女子性爱学校 大肥屁股重口味 啪啪啪啊啊啊不要 操碰 japanfreevideoshome国产 亚州淫荡老熟女人体 伦奸毛片免费在线看 天天影视se 樱桃做爱视频 亚卅av在线视频 x奸小说下载 亚洲色图图片在线 217av天堂网 东方在线撸撸-百度 幼幼丝袜集 灰姑娘的姐姐 青青草在线视频观看对华 86papa路con 亚洲1AV 综合图片2区亚洲 美国美女大逼电影 010插插av成人网站 www色comwww821kxwcom 播乐子成人网免费视频在线观看 大炮撸在线影院 ,www4KkKcom 野花鲁最近30部 wwwCC213wapwww2233ww2download 三客优最新地址 母亲让儿子爽的无码视频 全国黄色片子 欧美色图美国十次 超碰在线直播 性感妖娆操 亚洲肉感熟女色图 a片A毛片管看视频 8vaa褋芯屑 333kk 川岛和津实视频 在线母子乱伦对白 妹妹肥逼五月 亚洲美女自拍 老婆在我面前小说 韩国空姐堪比情趣内衣 干小姐综合 淫妻色五月 添骚穴 WM62COM 23456影视播放器 成人午夜剧场 尼姑福利网 AV区亚洲AV欧美AV512qucomwwwc5508com 经典欧美骚妇 震动棒露出 日韩丝袜美臀巨乳在线 av无限吧看 就去干少妇 色艺无间正面是哪集 校园春色我和老师做爱 漫画夜色 天海丽白色吊带 黄色淫荡性虐小说 午夜高清播放器 文20岁女性荫道口图片 热国产热无码热有码 2015小明发布看看算你色 百度云播影视 美女肏屄屄乱轮小说 家族舔阴AV影片 邪恶在线av有码 父女之交 关于处女破处的三级片 极品护士91在线 欧美虐待女人视频的网站 享受老太太的丝袜 aaazhibuo 8dfvodcom成人 真实自拍足交 群交男女猛插逼 妓女爱爱动态 lin35com是什么网站 abp159 亚洲色图偷拍自拍乱伦熟女抠逼自慰 朝国三级篇 淫三国幻想 免费的av小电影网站 日本阿v视频免费按摩师 av750c0m 黄色片操一下 巨乳少女车震在线观看 操逼 免费 囗述情感一乱伦岳母和女婿 WWW_FAMITSU_COM 偷拍中国少妇在公车被操视频 花也真衣论理电影 大鸡鸡插p洞 新片欧美十八岁美少 进击的巨人神thunderftp 西方美女15p 深圳哪里易找到老女人玩视频 在线成人有声小说 365rrr 女尿图片 我和淫荡的小姨做爱 � 做爱技术体照 淫妇性爱 大学生私拍b 第四射狠狠射小说 色中色成人av社区 和小姨子乱伦肛交 wwwppp62com 俄罗斯巨乳人体艺术 骚逼阿娇 汤芳人体图片大胆 大胆人体艺术bb私处 性感大胸骚货 哪个网站幼女的片多 日本美女本子把 色 五月天 婷婷 快播 美女 美穴艺术 色百合电影导航 大鸡巴用力 孙悟空操美少女战士 狠狠撸美女手掰穴图片 古代女子与兽类交 沙耶香套图 激情成人网区 暴风影音av播放 动漫女孩怎么插第3个 mmmpp44 黑木麻衣无码ed2k 淫荡学姐少妇 乱伦操少女屄 高中性爱故事 骚妹妹爱爱图网 韩国模特剪长发 大鸡巴把我逼日了 中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片 大胆女人下体艺术图片 789sss 影音先锋在线国内情侣野外性事自拍普通话对白 群撸图库 闪现君打阿乐 ady 小说 插入表妹嫩穴小说 推荐成人资源 网络播放器 成人台 149大胆人体艺术 大屌图片 骚美女成人av 春暖花开春色性吧 女亭婷五月 我上了同桌的姐姐 恋夜秀场主播自慰视频 yzppp 屄茎 操屄女图 美女鲍鱼大特写 淫乱的日本人妻山口玲子 偷拍射精图 性感美女人体艺木图片 种马小说完本 免费电影院 骑士福利导航导航网站 骚老婆足交 国产性爱一级电影 欧美免费成人花花性都 欧美大肥妞性爱视频 家庭乱伦网站快播 偷拍自拍国产毛片 金发美女也用大吊来开包 缔D杏那 yentiyishu人体艺术ytys WWWUUKKMCOM 女人露奶 � 苍井空露逼 老荡妇高跟丝袜足交 偷偷和女友的朋友做爱迅雷 做爱七十二尺 朱丹人体合成 麻腾由纪妃 帅哥撸播种子图 鸡巴插逼动态图片 羙国十次啦中文 WWW137AVCOM 神斗片欧美版华语 有气质女人人休艺术 由美老师放屁电影 欧美女人肉肏图片 白虎种子快播 国产自拍90后女孩 美女在床上疯狂嫩b 饭岛爱最后之作 幼幼强奸摸奶 色97成人动漫 两性性爱打鸡巴插逼 新视觉影院4080青苹果影院 嗯好爽插死我了 阴口艺术照 李宗瑞电影qvod38 爆操舅母 亚洲色图七七影院 被大鸡巴操菊花 怡红院肿么了 成人极品影院删除 欧美性爱大图色图强奸乱 欧美女子与狗随便性交 苍井空的bt种子无码 熟女乱伦长篇小说 大色虫 兽交幼女影音先锋播放 44aad be0ca93900121f9b 先锋天耗ばさ无码 欧毛毛女三级黄色片图 干女人黑木耳照 日本美女少妇嫩逼人体艺术 sesechangchang 色屄屄网 久久撸app下载 色图色噜 美女鸡巴大奶 好吊日在线视频在线观看 透明丝袜脚偷拍自拍 中山怡红院菜单 wcwwwcom下载 骑嫂子 亚洲大色妣 成人故事365ahnet 丝袜家庭教mp4 幼交肛交 妹妹撸撸大妈 日本毛爽 caoprom超碰在email 关于中国古代偷窥的黄片 第一会所老熟女下载 wwwhuangsecome 狼人干综合新地址HD播放 变态儿子强奸乱伦图 强奸电影名字 2wwwer37com 日本毛片基地一亚洲AVmzddcxcn 暗黑圣经仙桃影院 37tpcocn 持月真由xfplay 好吊日在线视频三级网 我爱背入李丽珍 电影师傅床戏在线观看 96插妹妹sexsex88com 豪放家庭在线播放 桃花宝典极夜著豆瓜网 安卓系统播放神器 美美网丝袜诱惑 人人干全免费视频xulawyercn av无插件一本道 全国色五月 操逼电影小说网 good在线wwwyuyuelvcom www18avmmd 撸波波影视无插件 伊人幼女成人电影 会看射的图片 小明插看看 全裸美女扒开粉嫩b 国人自拍性交网站 萝莉白丝足交本子 七草ちとせ巨乳视频 摇摇晃晃的成人电影 兰桂坊成社人区小说www68kqcom 舔阴论坛 久撸客一撸客色国内外成人激情在线 明星门 欧美大胆嫩肉穴爽大片 www牛逼插 性吧星云 少妇性奴的屁眼 人体艺术大胆mscbaidu1imgcn 最新久久色色成人版 l女同在线 小泽玛利亚高潮图片搜索 女性裸b图 肛交bt种子 最热门有声小说 人间添春色 春色猜谜字 樱井莉亚钢管舞视频 小泽玛利亚直美6p 能用的h网 还能看的h网 bl动漫h网 开心五月激 东京热401 男色女色第四色酒色网 怎么下载黄色小说 黄色小说小栽 和谐图城 乐乐影院 色哥导航 特色导航 依依社区 爱窝窝在线 色狼谷成人 91porn 包要你射电影 色色3A丝袜 丝袜妹妹淫网 爱色导航(荐) 好男人激情影院 坏哥哥 第七色 色久久 人格分裂 急先锋 撸撸射中文网 第一会所综合社区 91影院老师机 东方成人激情 怼莪影院吹潮 老鸭窝伊人无码不卡无码一本道 av女柳晶电影 91天生爱风流作品 深爱激情小说私房婷婷网 擼奶av 567pao 里番3d一家人野外 上原在线电影 水岛津实透明丝袜 1314酒色 网旧网俺也去 0855影院 在线无码私人影院 搜索 国产自拍 神马dy888午夜伦理达达兔 农民工黄晓婷 日韩裸体黑丝御姐 屈臣氏的燕窝面膜怎么样つぼみ晶エリーの早漏チ○ポ强化合宿 老熟女人性视频 影音先锋 三上悠亚ol 妹妹影院福利片 hhhhhhhhsxo 午夜天堂热的国产 强奸剧场 全裸香蕉视频无码 亚欧伦理视频 秋霞为什么给封了 日本在线视频空天使 日韩成人aⅴ在线 日本日屌日屄导航视频 在线福利视频 日本推油无码av magnet 在线免费视频 樱井梨吮东 日本一本道在线无码DVD 日本性感诱惑美女做爱阴道流水视频 日本一级av 汤姆avtom在线视频 台湾佬中文娱乐线20 阿v播播下载 橙色影院 奴隶少女护士cg视频 汤姆在线影院无码 偷拍宾馆 业面紧急生级访问 色和尚有线 厕所偷拍一族 av女l 公交色狼优酷视频 裸体视频AV 人与兽肉肉网 董美香ol 花井美纱链接 magnet 西瓜影音 亚洲 自拍 日韩女优欧美激情偷拍自拍 亚洲成年人免费视频 荷兰免费成人电影 深喉呕吐XXⅩX 操石榴在线视频 天天色成人免费视频 314hu四虎 涩久免费视频在线观看 成人电影迅雷下载 能看见整个奶子的香蕉影院 水菜丽百度影音 gwaz079百度云 噜死你们资源站 主播走光视频合集迅雷下载 thumbzilla jappen 精品Av 古川伊织star598在线 假面女皇vip在线视频播放 国产自拍迷情校园 啪啪啪公寓漫画 日本阿AV 黄色手机电影 欧美在线Av影院 华裔电击女神91在线 亚洲欧美专区 1日本1000部免费视频 开放90后 波多野结衣 东方 影院av 页面升级紧急访问每天正常更新 4438Xchengeren 老炮色 a k福利电影 色欲影视色天天视频 高老庄aV 259LUXU-683 magnet 手机在线电影 国产区 欧美激情人人操网 国产 偷拍 直播 日韩 国内外激情在线视频网给 站长统计一本道人妻 光棍影院被封 紫竹铃取汁 ftp 狂插空姐嫩 xfplay 丈夫面前 穿靴子伪街 XXOO视频在线免费 大香蕉道久在线播放 电棒漏电嗨过头 充气娃能看下毛和洞吗 夫妻牲交 福利云点墦 yukun瑟妃 疯狂交换女友 国产自拍26页 腐女资源 百度云 日本DVD高清无码视频 偷拍,自拍AV伦理电影 A片小视频福利站。 大奶肥婆自拍偷拍图片 交配伊甸园 超碰在线视频自拍偷拍国产 小热巴91大神 rctd 045 类似于A片 超美大奶大学生美女直播被男友操 男友问 你的衣服怎么脱掉的 亚洲女与黑人群交视频一 在线黄涩 木内美保步兵番号 鸡巴插入欧美美女的b舒服 激情在线国产自拍日韩欧美 国语福利小视频在线观看 作爱小视颍 潮喷合集丝袜无码mp4 做爱的无码高清视频 牛牛精品 伊aⅤ在线观看 savk12 哥哥搞在线播放 在线电一本道影 一级谍片 250pp亚洲情艺中心,88 欧美一本道九色在线一 wwwseavbacom色av吧 cos美女在线 欧美17,18ⅹⅹⅹ视频 自拍嫩逼 小电影在线观看网站 筱田优 贼 水电工 5358x视频 日本69式视频有码 b雪福利导航 韩国女主播19tvclub在线 操逼清晰视频 丝袜美女国产视频网址导航 水菜丽颜射房间 台湾妹中文娱乐网 风吟岛视频 口交 伦理 日本熟妇色五十路免费视频 A级片互舔 川村真矢Av在线观看 亚洲日韩av 色和尚国产自拍 sea8 mp4 aV天堂2018手机在线 免费版国产偷拍a在线播放 狠狠 婷婷 丁香 小视频福利在线观看平台 思妍白衣小仙女被邻居强上 萝莉自拍有水 4484新视觉 永久发布页 977成人影视在线观看 小清新影院在线观 小鸟酱后丝后入百度云 旋风魅影四级 香蕉影院小黄片免费看 性爱直播磁力链接 小骚逼第一色影院 性交流的视频 小雪小视频bd 小视频TV禁看视频 迷奸AV在线看 nba直播 任你在干线 汤姆影院在线视频国产 624u在线播放 成人 一级a做爰片就在线看狐狸视频 小香蕉AV视频 www182、com 腿模简小育 学生做爱视频 秘密搜查官 快播 成人福利网午夜 一级黄色夫妻录像片 直接看的gav久久播放器 国产自拍400首页 sm老爹影院 谁知道隔壁老王网址在线 综合网 123西瓜影音 米奇丁香 人人澡人人漠大学生 色久悠 夜色视频你今天寂寞了吗? 菲菲影视城美国 被抄的影院 变态另类 欧美 成人 国产偷拍自拍在线小说 不用下载安装就能看的吃男人鸡巴视频 插屄视频 大贯杏里播放 wwwhhh50 233若菜奈央 伦理片天海翼秘密搜查官 大香蕉在线万色屋视频 那种漫画小说你懂的 祥仔电影合集一区 那里可以看澳门皇冠酒店a片 色自啪 亚洲aV电影天堂 谷露影院ar toupaizaixian sexbj。com 毕业生 zaixian mianfei 朝桐光视频 成人短视频在线直接观看 陈美霖 沈阳音乐学院 导航女 www26yjjcom 1大尺度视频 开平虐女视频 菅野雪松协和影视在线视频 华人play在线视频bbb 鸡吧操屄视频 多啪啪免费视频 悠草影院 金兰策划网 (969) 橘佑金短视频 国内一极刺激自拍片 日本制服番号大全magnet 成人动漫母系 电脑怎么清理内存 黄色福利1000 dy88午夜 偷拍中学生洗澡磁力链接 花椒相机福利美女视频 站长推荐磁力下载 mp4 三洞轮流插视频 玉兔miki热舞视频 夜生活小视频 爆乳人妖小视频 国内网红主播自拍福利迅雷下载 不用app的裸裸体美女操逼视频 变态SM影片在线观看 草溜影院元气吧 - 百度 - 百度 波推全套视频 国产双飞集合ftp 日本在线AV网 笔国毛片 神马影院女主播是我的邻居 影音资源 激情乱伦电影 799pao 亚洲第一色第一影院 av视频大香蕉 老梁故事汇希斯莱杰 水中人体磁力链接 下载 大香蕉黄片免费看 济南谭崔 避开屏蔽的岛a片 草破福利 要看大鸡巴操小骚逼的人的视频 黑丝少妇影音先锋 欧美巨乳熟女磁力链接 美国黄网站色大全 伦蕉在线久播 极品女厕沟 激情五月bd韩国电影 混血美女自摸和男友激情啪啪自拍诱人呻吟福利视频 人人摸人人妻做人人看 44kknn 娸娸原网 伊人欧美 恋夜影院视频列表安卓青青 57k影院 如果电话亭 avi 插爆骚女精品自拍 青青草在线免费视频1769TV 令人惹火的邻家美眉 影音先锋 真人妹子被捅动态图 男人女人做完爱视频15 表姐合租两人共处一室晚上她竟爬上了我的床 性爱教学视频 北条麻妃bd在线播放版 国产老师和师生 magnet wwwcctv1024 女神自慰 ftp 女同性恋做激情视频 欧美大胆露阴视频 欧美无码影视 好女色在线观看 后入肥臀18p 百度影视屏福利 厕所超碰视频 强奸mp magnet 欧美妹aⅴ免费线上看 2016年妞干网视频 5手机在线福利 超在线最视频 800av:cOm magnet 欧美性爱免播放器在线播放 91大款肥汤的性感美乳90后邻家美眉趴着窗台后入啪啪 秋霞日本毛片网站 cheng ren 在线视频 上原亚衣肛门无码解禁影音先锋 美脚家庭教师在线播放 尤酷伦理片 熟女性生活视频在线观看 欧美av在线播放喷潮 194avav 凤凰AV成人 - 百度 kbb9999 AV片AV在线AV无码 爱爱视频高清免费观看 黄色男女操b视频 观看 18AV清纯视频在线播放平台 成人性爱视频久久操 女性真人生殖系统双性人视频 下身插入b射精视频 明星潜规测视频 mp4 免賛a片直播绪 国内 自己 偷拍 在线 国内真实偷拍 手机在线 国产主播户外勾在线 三桥杏奈高清无码迅雷下载 2五福电影院凸凹频频 男主拿鱼打女主,高宝宝 色哥午夜影院 川村まや痴汉 草溜影院费全过程免费 淫小弟影院在线视频 laohantuiche 啪啪啪喷潮XXOO视频 青娱乐成人国产 蓝沢润 一本道 亚洲青涩中文欧美 神马影院线理论 米娅卡莉法的av 在线福利65535 欧美粉色在线 欧美性受群交视频1在线播放 极品喷奶熟妇在线播放 变态另类无码福利影院92 天津小姐被偷拍 磁力下载 台湾三级电髟全部 丝袜美腿偷拍自拍 偷拍女生性行为图 妻子的乱伦 白虎少妇 肏婶骚屄 外国大妈会阴照片 美少女操屄图片 妹妹自慰11p 操老熟女的b 361美女人体 360电影院樱桃 爱色妹妹亚洲色图 性交卖淫姿势高清图片一级 欧美一黑对二白 大色网无毛一线天 射小妹网站 寂寞穴 西西人体模特苍井空 操的大白逼吧 骚穴让我操 拉好友干女朋友3p